Low-dose triamcinolone acetonide in the phytocosmetic Lichtena® reduces inflammation in mild to moderate atopic dermatitis

Dermatology

Volumn 211, Issue 4, 2005, Pages 338-340

  Pellanda, Carolina ^a   Weber, Monika ^a   Bircher, Andreas ^a   Surber, Christian ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Institut fur Spital Pharmazie   (Switzerland)

Author keywords

Atopic dermatitis; Extemporaneous compounding; Lichtena ; Low dose corticosteroids; Phytocosmetic; Severity Scoring of Atopic Dermatitis (SCORAD)

Indexed keywords

COSMETIC; LICHTENA; PLACEBO; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PHYTOTHERAPY; PLACEBOS; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VEHICLES;

EID: 27844482567     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088504     Document Type: Article

References (15)

1. Breuer K, Braeutigam M, Kapp A, Werfel T: Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis. Dermatology 2004;209:314-320.
2. Kagi MK: Leukotriene receptor antagonists - A novel therapeutic approach in atopic dermatitis? Dermatology 2001;203:280-283.
3. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, Schachner LA, Sidbury R, Whitmore SE: Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association 'Administrative Regulations for Evidence-Based Clinical Practice Guidelines'. J Am Acad Dermatol 2004;50:391-404.
4. Ernst E: The usage of complementary therapies by dermatological patients: A systematic review. Br J Dermatol 2000;142:857-861.
5. Ernst E: Adverse effects of herbal drugs in dermatology. Br J Dermatol 2000;143:923-929.
6. Report on the enquiry into fraudulent practice in the treatment of skin disease. A report of the All Party Parliamentary Group on Skin. London, December 1999.
7. Keane FM, Munn SE, du Vivier AWP, Taylor NF, Higgins EM: Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ 1999;318:563-564.
8. Bircher AJ, Surber C: Unregulated alternative medicine - Focus on. J Drugs Dermatol 2003;2:58-61.
9. Grassi A, Palermi G, Paradisi M: Study of tolerance and efficacy of cosmetic preparations with lenitive action in atopic dermatitis in children. Clin Ther 2000;151:77-80.
10. Hrubes B: Wirksamkeit und Verträglichkeit von Lichtena A.I. bei atopiscker Dermatitis; dissertation, Medizinische Fakultät Universität Basel, Basel, 2001.
11. Bircher AJ, Hauri U, Niederer M, Hohl C, Surber C: Stealth triamcinolone acetonide in a phytocosmetic cream. Br J Dermatol 2002;146:531-532.
12. Hanifin J, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;suppl 92:44-47.
13. Long CC, Mills CM, Finlay AY: A practical guide to topical therapy in children. Br J Dermatol 1998;138:293-296.
14. Severity Scoring of Atopic Dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31.
15. Ling MR: Extemporaneous compounding - The end of the road? Dermatol Clin 1998;16:321-327.